Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C news

Show

From To
Have a heart, save my liver!

Today, on the occasion of Valentine’s Day, Médecins du Monde and Treatment Action Group (TAG) launch an action urging pharmaceutical giants Merck and Roche to drop their exorbitant prices for pegylated interferon, an effective hepatitis C (HCV) treatment.

Published
14 February 2013
From
HepCoalition.org
Study: One-third of hepatitis B and C cases in Pakistan are preventable

Approximately one-third of all hepatitis B and C cases in Pakistan could be prevented by interventions directed towards a few modifiable risk factors, according to a recent study.

Published
14 February 2013
From
Vaccine News Daily (blog)
More evidence of sexual transmission of hepatitis C among HIV-positive gay men in the US

Investigators in the US have found a high incidence of hepatitis C virus (HCV) infection among HIV-positive gay men. Annual incidence was 1.6% – the highest ever

Published
14 February 2013
By
Michael Carter
HCV polymerase inhibitor mericitabine boosts interferon/ribavirin cure rate

A 24-week response-guided triple regimen consisting of Roche's NS5B polymerase inhibitor mericitabine plus pegylated interferon and ribavirin produced a greater likelihood of sustained viral suppression than a 48-week course of pegylated interferon/ribavirin alone, according to a report in the January 28, 2013, online advance edition of Hepatology.

Published
13 February 2013
From
HIVandHepatitis.com
FISSION Study Should Support Regulatory Approval For Gilead's Hepatitis C Drug

On Monday, Gilead announced positive top‐line results from two Phase III studies (FISSION and NEUTRINO) that involve the use of sofosbuvir in combination with other agents for use in treatment‐naïve patients infected with the Hepatitis C virus (HCV).

Published
07 February 2013
From
Seeking Alpha
Launch of New Patient-Focused Website at LiverCancerConnect.org

The website aims to help people better understand how liver cancer is diagnosed and how it can be treated or prevented. In addition, wwwLiverCancerConnect.org includes a Drug Watch of potential new liver cancer therapies, an expanding directory of liver cancer specialists, and a clinical trials listing.

Published
07 February 2013
From
Hepatitis B Foundation
The Evolution of How Drug Injection Equipment Harbors Hep C

We know that injection drug users represent the single largest risk group for Hepatitis C, but we just recently learned how vulnerable their equipment is.

Published
06 February 2013
From
Hepatitis Central
95 patients infected with hepatitis C linked to Chinese clinic

Ninety-five people have been hospitalized after a private clinic gave them injections suspected to be contaminated with hepatitis C, Chinese state media say.

Published
06 February 2013
From
CBS News
IL28B genotype had limited effect on telaprevir response in HCV patients

Patients with interleukin 28B CC genotype had a slightly better response to hepatitis C treatment with pegylated interferon, ribavirin and telaprevir than those with the CT or TT genotypes in a recent study.

Published
06 February 2013
From
Healio Hepatology
Idenix to Discontinue Development of Two Hepatitis C Treatments

Idenix Pharmaceuticals today announced the Company has elected not to continue its clinical development program for IDX184, a nucleotide polymerase inhibitor in phase IIb testing for the treatment of hepatitis C virus (HCV) infection, or to continue its development of IDX19368, an HCV nucleotide polymerase inhibitor for which the Company had previously filed an IND but had not initiated patient dosing.

Published
05 February 2013
From
Idenix press release

Filter by country